FY2024
Effective from
- Added
Lafora progressive myoclonus epilepsy, not intractable
Category — select a more specific code
CDC/NCHS · FY2024, if applicable, associated conditions such as dementia (F02.8-)
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2023-10-01
Latest recorded change · FY2024
Effective from
Lafora progressive myoclonus epilepsy, not intractable
Category — select a more specific code
CDC/NCHS · FY2024| All editions | Effective from | Code history |
|---|---|---|
| FY2024 | 2023-10-01 | Added |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
The official Tabular List has no additional instructions at this code level.
Review the instructions inherited from its parent categories below. Inherited instructions ↓
the following terms are to be considered equivalent to intractable: pharmacoresistant (pharmacologically resistant), treatment resistant, refractory (medically) and poorly controlled
Lafora body disease
, if applicable, associated conditions such as dementia (F02.8-)
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| G40.C1 | Lafora progressive myoclonus epilepsy, intractable | Category · further specificity required |
Official titles and instructions are preserved in their source language. Official sources ↗